222. Primary nephrotic syndrome Clinical trials / Disease details


Clinical trials : 285 Drugs : 285 - (DrugBank : 108) / Drug target genes : 62 - Drug target pathways : 191

  
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1EUCTR2017-002674-39-IT
(EUCTR)
03/08/201808/06/2021A treatment study of ACH-0144471 in Patients with C3 Glomerulopathy (C3G) or Immune-Complex Membranoproliferative Glomerulonephritis (ICMPGN)An Open-Label Phase 2 Proof-of-Concept Study in Patients with C3 Glomerulopathy (C3G) or Immune-Complex Membranoproliferative Glomerulonephritis (IC-MPGN) Treated with ACH-0144471 - N/A C3 Glomerulopathy (C3G) or idiopathic Immune-Complex Membranoproliferative Glomerulonephritis (IC-MPGN)
MedDRA version: 20.1;Level: PT;Classification code 10018364;Term: Glomerulonephritis;System Organ Class: 10038359 - Renal and urinary disorders;Therapeutic area: Diseases [C] - Immune System Diseases [C20]
Product Name: ACH-0144471 compresse
Product Code: ACH-0144471
INN or Proposed INN: ACH-0144471
Product Name: ACH-0144471 compresse
Product Code: ACH-0144471
INN or Proposed INN: ACH-0144471
Product Name: ACH0144471 compresse
Product Code: ACH0144471
INN or Proposed INN: ACH-0144471
Trade Name: TETRACT-HIB - 1 SIRINGA PRECARICATA 0.5 ML
Product Name: ACT-HIB
Product Code: [ACT-HIB]
Product Name: Bexsero
Product Code: [Bexsero]
Product Name: Menveo
Product Code: [Menveo]
Trade Name: PREVENAR 13 - 0.5 ML SOSPENSIONE INIETTABILE - USO INTRAMUSCOLARE - FLACONCINO MONODOSE (0,5 ML VETRO TIPO I) - 1 FLACONCINO MONODOSE
Product Name: Prevenar 13
Product Code:
ACHILLION PHARMACEUTICALS, INC.NULLNot RecruitingFemale: yes
Male: yes
20Phase 2United States;Belgium;Australia;Netherlands;Italy